(Reuters) – Eli Lilly & Co. has resolved a lawsuit filed in March by a prominent former lobbyist who accused a high-ranking executive and other senior executive of engaging in acts of gender discrimination, harassment and retaliation against women in his Washington office, according to a court filing Monday.
The lawsuit, filed in federal court in Washington by inside lobbyist Sonya Elling, alleged that a senior vice president of Lilly, Leigh Ann Pusey, had repeatedly humiliated Ms Elling and other women, and ultimately forced Elling to resign.
Ms Pusey, senior vice president of corporate affairs and communications, was one of CEO Dave Ricks’ first appointments when he took over as the drugmaker in 2017.
Lilly has previously denied the allegations against Ms Pusey. A spokesperson for Lilly declined to comment on Tuesday. Ms. Pusey could not be reached.
As part of the resolution, Ms Elling agreed to dismiss the lawsuit, according to a court record filed on Monday. The issues were not raised in court and the terms of the settlement were not disclosed.
“We settled things amicably,” Elling’s lawyer Lynne Bernabei told Reuters on Tuesday.
The lawsuit came as further allegations of improper actions or retaliation by Lilly executives against employees surfaced.
In February, Lilly announced that the company’s chief financial officer, Josh Smiley, had resigned. Lilly said in a securities filing Feb. 9 that Mr. Smiley had “consensual but inappropriate personal communications” with employees. Mr. Smiley declined to comment.
Reuters reported in March that a former human resources manager at Lilly complained in a legal notice that she was forced to quit her job at a New Jersey factory after launching internal investigations alleging various misconduct. to manufacturing.